How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Stereotactic Planning Software Market
- By Application: Deep Brain Stimulation (DBS), Stereotactic Radiosurgery (SRS), Biopsy and Lesion Localization, Functional Neurosurgery, Epilepsy Surgery Planning
- By Modality Compatibility: MRI-based Planning, CT-based Planning, PET-based Planning, Multimodal Imaging Integration
- By End User: Hospitals and Clinics, Research Institutes, Ambulatory Surgical Centers, Academic Medical Centers
- By Software Deployment Model: On-premise Software, Cloud-based Software, Hybrid Deployment
- By Functionality: Image Fusion and Registration, Trajectory Planning, Dose Calculation and Simulation, 3D Visualization and Modeling, Automated Target Identification
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Deep Brain Stimulation (DBS) leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Stereotactic Planning Software Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application 5
Modality Compatibility 4
End User 4
Software Deployment Model 3
Functionality 5
Companies profiled
Medtronic
Brainlab AG
Elekta AB
Varian Medical Systems (a Siemens Healthineers company)
Accuray Incorporated
Philips Healthcare
GE Healthcare
Siemens Healthineers
IntraOp Medical Corporation
Stryker Corporation
CIVCO Radiotherapy
Mazor Robotics (part of Medtronic)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Brainlab AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Elekta AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Varian Medical Systems (a Siemens Healthineers company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Accuray Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Siemens Healthineers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →IntraOp Medical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →CIVCO Radiotherapy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Mazor Robotics (part of Medtronic)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Renishaw plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Stereotaxis Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Radionics (Integra LifeSciences)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,226M by 2033 · 4.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Deep Brain Stimulation (DBS)47.0
- Stereotactic Radiosurgery (SRS)17.5
- Biopsy and Lesion Localization12.0
- Functional Neurosurgery14.5
- Epilepsy Surgery Planning9.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$985.9M → $1,449M · 4.9%
Europe$687.2M → $965.0M · 4.3%
Asia Pacific$627.4M → $918.9M · 4.9%
Latin America$388.4M → $499.0M · 3.2%
Middle East and Africa$298.8M → $476.2M · 6.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.382026
4.392027
4.412028
4.422029
4.432030
4.452031
4.452032
4.472033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic23.1
- Brainlab AG15.7
- Elekta AB4.6
- Varian Medical Systems (a Siemens Healthineers company)9.5
- Accuray Incorporated7.5
- Philips Healthcare11.5
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Application18.2%
Modality Compatibility21.8%
End User13.8%
Software Deployment Model31.1%
Functionality15.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe22.4
- Asia Pacific21.3
- Latin America11.6
- Middle East and Africa11.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 95 | 85 | 77 | 85 | 78 | 90 | 85 |
| Brainlab AG | 71 | 88 | 80 | 80 | 83 | 92 | 82 |
| Elekta AB | 68 | 77 | 67 | 63 | 86 | 81 | 74 |
| Varian Medical Systems (a Siemens Healthineers company) | 58 | 74 | 76 | 66 | 63 | 65 | 67 |
| Accuray Incorporated | 51 | 70 | 60 | 68 | 55 | 68 | 62 |
| Philips Healthcare | 65 | 61 | 61 | 62 | 67 | 58 | 62 |
| GE Healthcare | 62 | 53 | 55 | 42 | 54 | 47 | 52 |
| Siemens Healthineers | 58 | 40 | 36 | 37 | 43 | 45 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Brainlab AG
- Elekta AB
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Brainlab AG | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Elekta AB | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Varian Medical Systems (a Siemens Healthineers company) | ◐ | ◐ | − | ◐ | − | ◐ |
| Accuray Incorporated | − | ◐ | ◐ | ◐ | ◐ | − |
| Philips Healthcare | − | − | ◐ | ◐ | − | ◐ |
| GE Healthcare | ◐ | ◐ | ◐ | − | ◐ | − |
| Siemens Healthineers | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic85
2Brainlab AG82
3Elekta AB74
4Varian Medical Systems (a Siemens Healthineers company)67
5Accuray Incorporated62
6Philips Healthcare62
7GE Healthcare52
8Siemens Healthineers43
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicBrainlab AG
Challenger2
Strong scale, closing on the leaders.
Elekta ABVarian Medical Systems (a Siemens Healthineers company)
Contender2
Focused players with pockets of strength.
Accuray IncorporatedPhilips Healthcare
Niche2
Specialists in a single segment or region.
GE HealthcareSiemens Healthineers
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Stereotactic Planning Software Market — a $427M beachhead inside a $6.08B market.
Beachhead (SOM)$427Mobtainable near-term
Serviceable (SAM)$2.55Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Deep Brain Stimulation (DBS)
Best fit — highest urgency & budget in Application.
Economic buyer80 fit
Stereotactic Radiosurgery (SRS)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Biopsy and Lesion Localization
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Modality Compatibility & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel27%
Digital / self-serve23%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Stereotactic Planning Software Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified24%
Evaluation14%
Closed-won5%
$14.8KCAC
$81KLTV
5.5:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Stereotactic Planning Software Market is a durable-growth opportunity — $1.08B by 2033, compounding at 7.0%.
TAM · 2025$629Mtoday
TAM · 2033$1.08Bforecast
CAGR7.0%2027–2033
Cumulative$7.53Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.08BTotal addressable market
SAM$431MServiceable available market
SOM$82MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.0% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.08BLarge & growingTAM by 2033 at 7.0% CAGR
$431MServiceable nowreachable with today’s model
$82MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$841MBear4.5% CAGR
$1.08BBase7.0% CAGR
$1.38BBull9.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Modality Compatibility optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Stereotactic Planning Software Market — a $5.88B market by 2033. Plan: grow share from 6.5% to 13.8%.
Market size · 2033$5.88Btotal addressable
Market CAGR5.9%2027–2033
Target share13.8%from 6.5% today
Revenue ambition$812Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.5% | 13.8% | At risk |
| Revenue | $377M | $812M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 33.7% | 45.4% | Ahead |
| Customer retention | 91.0% | 93.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Modality Compatibility capability
A defensible second engine — invest in Modality Compatibility to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Modality Compatibility
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $91M capacity & capability investment
- Greenlight bolt-on M&A in Modality Compatibility
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Stereotactic Planning Software Market conversation — a $2.10B market you can size, segment and defend in minutes.
Market size · 2033$2.10Btotal opportunity
Growth9.2%CAGR to 2033
Addressable buyers1,749+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 2 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MedtronicBrainlab AGElekta ABVarian Medical Systems (a Siemens Healthineers company)Accuray IncorporatedPhilips HealthcareGE HealthcareSiemens Healthineers+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Stereotactic Planning Software Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Stereotactic Planning Software Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Stereotactic Frame for Veterinary Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportStereotactic Breast Biopsy System Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportStereoscopic Optical Microscopes Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportStereo Microscopes Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportStereo Colposcopy Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportStepper Pipettes Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportStephania Extract Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportStent Test Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportStent Retriever Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportStentless Bioprostheses Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportStent Grafts Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportStent Fire Sprinkler Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.